Related Experiment Video
Updated: Nov 25, 2025
In Vitro Assays to Evaluate the Migration, Invasion, and Proliferation of Immortalized Human First-trimester Trophoblast Cell Lines
Published on: March 5, 2019
Dexamethasone Reduces Cell Adhesion and Migration of T47D Breast Cancer Cell Line
Leila Mohammadi1,2, Bashir Mosayyebi2, Mahsa Imani2
1Student Research Committee, Tabriz University of Medical Science, Tabriz, Iran.
Background:
Aberrant expression of cell adhesion molecules and matrix metalloproteinase (MMPs) plays a pivotal role in tumor biological processes, including progression and metastasis of cancer cells. Targeting these processes and acquiring a detailed understanding of their underlying molecular mechanism are an essential step in cancer treatment. Dexamethasone (Dex) is a type of synthetic corticosteroid hormone used as adjuvant therapy in combination with current cancer treatments such as chemotherapy in order to alleviate its side effects like acute nausea and vomiting. Recent evidences suggest that Dex may have antitumor characteristics.
Objective:
Dex affects the migration and adhesion of T47D breast cancer cells as well as cell adhesion molecules, e.g. cadherin and integrin, and MMPs by regulating the expression levels of associated genes.
Methods:
In this study, we evaluated the cytotoxicity of Dex on the T47D breast cancer cell line through MTT assay. Cell adhesion assay and wound healing assay were performed to determine the impact of Dex on cell adhesion and cell migration, respectively. Moreover, real-time PCR was used to measure the levels of α and β integrin, E-cadherin, N-cadherin, MMP-2, and MMP-9.
Results:
Dex decreased the viability of T47D cells in a time and dose-dependent manner. Cell adhesion and migration of T47D cells were reduced upon Dex treatment. The expressions of α and β integrin, E-cadherin, Ncadherin, MMP-2, and MMP-9 were altered in response to the Dex treatment.
Conclusion:
Our findings demonstrated that Dex may play a role in the prevention of metastasis in this cell line.
Insights
Dexamethasone (Dex) reduces breast cancer cell viability, adhesion, and migration. This synthetic corticosteroid hormone also alters the expression of key genes involved in metastasis, suggesting a potential role in cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Aberrant expression of cell adhesion molecules and matrix metalloproteinases (MMPs) is crucial in cancer progression and metastasis.
- Dexamethasone (Dex), a synthetic corticosteroid, is used in cancer therapy to mitigate chemotherapy side effects and shows potential antitumor properties.
Purpose of the Study:
- To investigate the effects of Dexamethasone (Dex) on T47D breast cancer cell line.
- To evaluate Dex's impact on cell viability, adhesion, migration, and the expression of associated genes.
Main Methods:
- Cytotoxicity was assessed using MTT assay.
- Cell adhesion and migration were evaluated through cell adhesion and wound healing assays.
- Gene expression levels of integrins (α and β), cadherins (E- and N-), MMP-2, and MMP-9 were quantified using real-time PCR.
Main Results:
- Dex exhibited time- and dose-dependent cytotoxicity against T47D cells.
- Dexamethasone treatment significantly reduced T47D cell adhesion and migration.
- Dex altered the expression of integrins, cadherins, MMP-2, and MMP-9 in T47D cells.
Conclusions:
- Dexamethasone demonstrates potential anti-metastatic effects in T47D breast cancer cells.
- Dex influences key molecular pathways involved in cancer cell adhesion, migration, and invasion.
